Nearly 40,000 frozen blood samples collected during one of the largest U.S. studies of high blood pressure may soon reveal critical clues about who is most at risk for Alzheimer’s disease and dementia — and a Phoenix researcher is helping to lead the charge.

INDUSTRY INSIGHTS: Want more news like this? Get our free newsletter here

The National Institutes of Health (NIH) has awarded a $21.6 million, five-year grant to a team of researchers, including Banner Alzheimer’s Institute, to explore how hypertension may contribute to brain disease. Their work will focus on identifying molecules in blood that signal the earliest stages of Alzheimer’s and related dementias.

This groundbreaking study represents a first-of-its-kind approach that positions Banner Alzheimer’s Institute at the foref

See Full Page